在神经退行性疾病中,NADPH氧化酶4 (NOX4) 作为生物标志物和治疗点
相关实验视频
Updated: Jul 5, 2025

09:25
ROS Live Cell Imaging During Neuronal Development
Published on: February 9, 2021
4.3K
Napissara Boonpraman1, Sun Shin Yi1,2,3
1BK21 four Program, Department of Medical Sciences, Soonchunhyang University, Asan, South Korea.
Neural regeneration research
|January 16, 2024
概括
在星球细胞中准NADPH氧化酶4 (NOX4) 通过减少氧化应激和炎症,为阿尔茨海默氏症和帕金森症等神经退行性疾病提供了一种新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 像阿尔茨海默氏症和帕金森症这样的神经退行性疾病的特征是由于氧化应激和炎症而引起的神经元损伤.
- NADPH氧化酶4 (NOX4) 是中枢神经系统中一个关键的反应性氧物种发生器,与这些病理有关.
研究的目的:
- 本综述阐明了NOX4在神经炎症和神经元功能障碍中的作用.
- 它探讨了将NOX4向天体细胞内作为神经退行性疾病的潜在治疗方法.
主要方法:
- 该综述综合了当前关于NOX4在质细胞,特别是天体细胞中的功能研究.
- 它检查了NOX4活动对氧化应激和炎症标志物的影响.
主要成果:
- 功能障碍的星体细胞通过分泌反应性氧物种和炎症因子,导致神经退行.
- 在星球细胞中调节NOX4显示出降低氧化损伤和神经炎症的潜力.
结论:
- NADPH氧化酶4 (NOX4) 是神经炎症和神经元损伤的关键因素,使其成为一个有前途的药物标.
- 向天体细胞中的NOX4可以通过影响关键的炎症性细胞因子,为阿尔茨海默氏症和帕金森病提供新的治疗策略.
相关概念视频
Electron Transport Chain: Complex I and II
13.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K

